Doctors Note Logo

Published on: 9/23/2026

What is a teratoma tumor, and is it cancerous?

A teratoma is a rare germ cell tumor that contains different tissue types, such as hair, muscle, teeth, bone, or fat, and it most often develops in the ovaries, testicles, or tailbone. Whether it is cancerous depends on the type: mature teratomas are usually benign, while immature teratomas can be malignant and may spread, and a small number of mature tumors can become cancerous over time. Age, location, tumor markers, and imaging all influence the diagnosis and treatment plan, which typically involves surgical removal and sometimes chemotherapy, so there are several important details to weigh before assuming a teratoma is harmless, all explained in the complete answer below. Because vague symptoms like pelvic pain, bloating, swelling, or a palpable lump overlap with many far more common conditions, guessing at the cause can lead to unnecessary worry or dangerous delays.

Take a few minutes to complete a free, instant, online symptom check to see which conditions may match what you are feeling and learn which type of doctor and tests to ask about next.

Last reviewed for medical accuracy: 09/23/2026

answer background

Explanation

What Is a Teratoma Tumor, and Is It Cancerous?

A teratoma tumor is a type of growth that arises from germ cells—those early cells in the embryo that can develop into eggs or sperm. Unusual in their make-up, teratomas can contain a mix of tissues like hair, muscle, bone or even teeth. While most teratomas are benign (non-cancerous), some can be immature or undergo malignant transformation, requiring careful evaluation and treatment.


How Teratoma Tumors Develop

  • Origin
    Teratomas arise from pluripotent germ cells. These cells have the potential to become any cell type in the body, which is why teratomas may contain a surprising array of tissues.
  • Locations
    • Gonadal: ovaries in women, testes in men
    • Extragonadal: chest (mediastinum), lower back (sacrococcygeal region), brain, neck or abdomen
  • Age and Gender
    • Common in infants and young adults
    • Sacrococcygeal teratomas are often found at birth
    • Ovarian teratomas (dermoid cysts) typically occur in women of reproductive age

Types of Teratoma Tumors

  1. Mature Teratoma

    • Composed of well-differentiated (adult-like) tissues
    • Often cystic and filled with hair or sebaceous material
    • Usually benign
  2. Immature Teratoma

    • Contains undeveloped (embryonic-type) tissues
    • Higher risk of malignancy
    • Graded by the amount of immature neural tissue present
  3. Monodermal Teratoma (e.g., Struma Ovarii)

    • Predominantly one tissue type (thyroid, neural, etc.)
    • May have unique hormone-related effects
  4. Malignant Teratoma (Teratocarcinoma)

    • Rare transformation into cancer
    • May include other germ cell tumor elements like yolk sac or choriocarcinoma components

Are Teratoma Tumors Cancerous?

  • Benign vs. Malignant

    • Most mature teratomas are benign. They grow slowly and do not spread.
    • Immature teratomas carry a higher risk of malignancy. The greater the proportion of immature tissue, the greater the risk.
    • Malignant transformation is rare but possible; elements such as carcinoma or sarcoma may develop within a teratoma.
  • Risk Factors for Malignancy

    • Age (adult sacrococcygeal teratomas have higher risk than infant cases)
    • Location (mediastinal teratomas can be more aggressive)
    • Histologic grade (amount of immature neural tissue)

Signs and Symptoms

Symptoms vary by size and location. Large teratomas may press on nearby organs or nerves.

Common presentations include:

  • Abdominal or pelvic discomfort
  • Swelling or palpable mass in the groin, abdomen or back
  • Bowel or bladder changes (constipation, urinary frequency)
  • Chest pain or shortness of breath (mediastinal teratomas)
  • Neurologic signs if pressing on spinal nerves (sacrococcygeal region)

Some teratomas are found incidentally during imaging for unrelated issues.


Diagnosing a Teratoma Tumor

  1. Imaging Studies

    • Ultrasound (first choice for ovarian/testicular masses)
    • CT scan or MRI (detail tissue components and guide surgery)
  2. Blood Tests

    • Tumor markers like alpha-fetoprotein (AFP), beta-hCG and LDH can suggest germ cell activity
    • Normal markers with imaging findings often point to a mature teratoma
  3. Biopsy or Surgical Removal

    • Definitive diagnosis relies on microscopic exam of tissue
    • Identifies mature vs. immature elements and checks for malignant cells

Treatment Options

  • Surgical Removal

    • Mainstay for both benign and malignant teratomas
    • Complete excision prevents recurrence and confirms diagnosis
  • Chemotherapy

    • Recommended for high-grade immature teratomas or teratocarcinomas
    • Regimens often combine drugs like platinum agents and etoposide
  • Radiation Therapy

    • Rarely used, but may be considered for certain malignant transformations
  • Follow-Up

    • Regular imaging and blood tests to monitor for recurrence or malignant change

Outlook and Prognosis

  • Mature (Benign) Teratomas

    • Excellent prognosis after complete removal
    • Low recurrence if fully excised
  • Immature and Malignant Teratomas

    • Prognosis depends on stage, grade and response to chemotherapy
    • Early detection and aggressive treatment improve outcomes
  • Long-Term Monitoring

    • Critical for high-risk cases to catch recurrences early
    • Lifelong follow-up may be advised for certain locations (e.g., mediastinum)

When to Seek Medical Advice

A persistent mass, unrelenting pain, or changes in bowel/bladder habits should prompt evaluation. You might also consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to help determine whether you need urgent care.


Key Takeaways

  • A teratoma tumor arises from germ cells and can contain diverse tissues.
  • Most mature teratomas are benign; immature forms carry cancer risk.
  • Diagnosis relies on imaging, blood markers and tissue sampling.
  • Surgery is the cornerstone of treatment; chemotherapy for malignant cases.
  • Prognosis is excellent for benign teratomas; variable for malignant ones.
  • Always follow up regularly to monitor for any changes.

If you notice any masses, persistent pain, or unexplained symptoms, speak to a doctor promptly. Only a medical professional can provide the personalized evaluation and care you need, especially for anything that could be life threatening or serious.

(References)

  • * Cohen D, Bale PM, Painter DM. Teratomas in childhood. An Esp Pediatr. 1976 Dec;9(9):69-72. PMID: 1015694.

  • * Bale PM, Painter DM, Cohen D. Teratomas in childhood. Pathology. 1975 Jul;7(3):209-18. doi: 10.3109/00313027509094411. PMID: 1196679.

  • * Ashcraft KW, Holder TM, Harris DJ. Familial presacral teratomas. Birth Defects Orig Artic Ser. 1975;11(5):143-6. PMID: 1218206.

  • * SOTOPACHECO L, FERNANDEZSOTO A, JARAMILLOANTILLON J. [TERATOMAS]. Rev Med Costa Rica. 1963 Jul;20:249-72. PMID: 14053800.

  • * Sánchez-Cifuentes A, Gonzalez-Valverde FM, Vicente-Ruiz M, Peña-Ros E, Pastor-Quirante F, Albarracín-Marín-Blázquez A, Escamilla-Segade C. [Peritoneal gliomatosis]. Cir Cir. 2014 Jul-Aug;82(4):432-5. PMID: 25167355.

  • * Chaudhry R, Qamar MN, Riaz A. Mature Orbital Teratoma. J Coll Physicians Surg Pak. 2021 May;31(5):596-598. doi: 10.29271/jcpsp.2021.05.596. PMID: 34027878.

  • * Atwi D, Kamal M, Quinton M, Hassell LA. Malignant transformation of mature cystic teratoma of the ovary. J Obstet Gynaecol Res. 2022 Dec;48(12):3068-3076. doi: 10.1111/jog.15409. Epub 2022 Sep 2. PMID: 36053141.

  • * Cong L, Wang S, Yeung SY, Lee JHS, Chung JPW, Chan DYL. Mature Cystic Teratoma: An Integrated Review. Int J Mol Sci. 2023 Mar 24;24(7). doi: 10.3390/ijms24076141. Epub 2023 Mar 24. PMID: 37047114; PMCID: PMC10093990.

  • * Olesen CS, Hjelvang BR, Brøchner CB, Maroun LL, Jørgensen FS. [Fetal intracranial immature teratoma]. Ugeskr Laeger. 2025 Oct 20;187(43). doi: 10.61409/V05250364. Epub 2025 Oct 20. PMID: 41251245.

  • * van Heurn LJ, Derikx JPM, Hall NJ, AbouZeid AA, de Campos Vieira Abib S, Chirdan LB, Fumino S, Kim SC, Muensterer O, Olivos M, StPeter SD, Twisk J, Vinit N, Yang T, Zani A, Ernst van Heurn LW, SCT-study consortium. Malignant transformation of sacrococcygeal teratoma versus presacral teratoma in Currarino syndrome: Results of 'The SCT-study'. J Pediatr Surg. 2026 Jun;61(6):162848. doi: 10.1016/j.jpedsurg.2025.162848. Epub 2026 Mar 30. PMID: 42250912.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.